Neuraminidase from Clostridium perfringens (C. welchii)
SIGMA/N2876 - Suitable for manufacturing of diagnostic kits and reagents, Type V, lyophilized powder
Synonym: Acyl-neuraminyl Hydrolase; Receptor-destroying enzyme; Sialidase
CAS Number: 9001-67-6
EC Number: 232-624-6
MDL Number: MFCD00131711
Product Type: Chemical
| application(s) | diagnostic assay manufacturing |
| foreign activity | Protease and NAN-aldolase, present |
| form | lyophilized powder |
| Quality Level | 300 ![]() |
| shipped in | dry ice |
| specific activity | ≥0.1 units/mg solid (using mucin) |
| ≥1.3 units/mg solid (using 4MU-NANA) | |
| storage temp. | −20°C |
| type | Type V |
| Analysis Note: | Package sizes based on 4MU-NANA units |
| Analysis Note: | Package sizes based on the 4MU-NANA units |
| Application: | Neuraminidase from Clostridium perfringens has been used in a study to assess binding with human T lymphocytes in sheep pretreated with neuraminidase. It has also been used in a study to investigate the effect of bile salts on the action of hydrolysis by neuraminidase. |
| Biochem/physiol Actions: | Neuraminidase can increase aggregation in certain cell lines by removing exposed negatively charged sialic acid residues on the cell surface. |
| Biochem/physiol Actions: | Neuraminidase cleavage of sialic acid groups has been used to study recognition by antibodies of glycoprotein structures. The use of neuraminidase in the estimation of N-acetylneuraminic acid was compared favorably to two other methods. |
| Biochem/physiol Actions: | Neuraminidases are used to cleave terminal N-acetyl neuraminic acid (sialic acid) from a variety of glycoproteins. The enzyme from Clostridium perfringens cleaves terminal sialic acid residues which are α-2,3- α-2,6- or α-2,8-linked to Gal, GlcNac, GalNAc, AcNeu, GlcNeu, oligosaccharides, glycolipids or glycoproteins. The relative rate of cleavage decreases in the order: α-2-3 > α-2-6 . α-2-8. Neuraminidase from C. perfringens cleaves α-2-3 linked sialic acid residues most efficiently, compared to A. ureafaciens, (Sigma N3642) which preferentially cleaves α-2-6 linked residues. |
| Biochem/physiol Actions: | The use of neuraminidase to remove sialic acid residues from glycoproteins on cell surfaces has been frequently reported. Generally, procedures have indicated using neuraminidase in PBS at 37°C for 30 minutes, followed by several washings with PBS. Treatment of tissue sections with neuraminidase at much lower concentrations require longer incubation: for 1-4 U/mL in 0.1 M acetate buffer pH 4.2-5, from 2 to 20 hours at 37 °C. |
| General description: | Neuraminidase enzymes are hydrolase enzymes that promote influenza virus release from infected cells and facilitate virus spread. |
| Other Notes: | One unit will liberate 1.0 micromole of N-acetyl neuraminic acid per minute at pH 5.0 at 37 °C using bovine submaxillary mucin. One unit will hydrolyze 1.0 micromole of 2′-(4-methylumbelliferyl) |
| Packaging: | 2.5, 6 units in glass bottle |
| Packaging: | 25, 250 units in poly bottle |
| Preparation Note: | Prepared by salt fractionation. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| activity | specific activity: ≥0.1 units/mg solid (using mucin); specific activity: ≥1.3 units/mg solid (using 4MU-NANA) |
| Storage Temp. | −20°C |
| Enzyme Commission (EC) Number | 3.2.1.18 ( BRENDA ![]() ![]() |
| UNSPSC | 12352204 |

